Kinslow, C. J., DeStephano, D. M., Rohde, C. H., Kachnic, L. A., Cheng, S. K., Neugut, A. I., & Horowitz, D. P. (2022). Risk of Anaplastic Large Cell Lymphoma Following Postmastectomy Implant Reconstruction in Women With Breast Cancer and Ductal Carcinoma in Situ. JAMA Network Open, 5(11), e2243396. https://doi.org/10.1001/jamanetworkopen.2022.43396

Parada, H., Sahrai, L., Wolff, M. S., Santella, R. M., Chen, J., Neugut, A. I., & Teitelbaum, S. L. (2022). Urinary parabens and breast cancer risk: Modification by LINE‐1 and LUMA global DNA methylation, and associations with breast cancer defined by tumor promoter methylation status. Molecular Carcinogenesis, 61(11), 1002–1015. Portico. https://doi.org/10.1002/mc.23456

McCarthy, A. M., Manning, A. K., Hsu, S., Welch, M., Moy, B., Lehman, C. D., & Armstrong, K. (2022). Breast cancer polygenic risk scores are associated with short-term risk of poor prognosis breast cancer. Breast Cancer Research and Treatment, 196(2), 389–398. https://doi.org/10.1007/s10549-022-06739-5

Li, Q., Lesseur, C., Neugut, A. I., Santella, R. M., Parada, H., Teitelbaum, S., & Chen, J. (2022). The associations of healthy lifestyle index with breast cancer incidence and mortality in a population-based study. Breast Cancer, 29(6), 957–966. https://doi.org/10.1007/s12282-022-01374-w

Trivedi, M. S., Arber, N., Friedman, E., Garber, J. E., Holcomb, K., Horowitz, N. S., Wright, J. D., Lee, J. J., Vornik, L. A., Abutaseh, S., Castile, T., Sauter, E. R., Dimond, E., Heckman-Stoddard, B. M., House, M., Samimi, G., Brown, P. H., & Crew, K. D. (2022). Lessons from the Failure to Complete a Trial of Denosumab in Women With a Pathogenic BRCA1/2 Variant Scheduling Risk-Reducing Salpingo-Oophorectomy. Cancer Prevention Research, 15(11), 721–726. https://doi.org/10.1158/1940-6207.capr-22-0051

Hakkaart, C., Pearson, J. F., Marquart, L., Dennis, J., Wiggins, G. A. R., Barnes, D. R., Robinson, B. A., Mace, P. D., Aittomäki, K., Andrulis, I. L., Arun, B. K., Azzollini, J., Balmaña, J., Barkardottir, R. B., Belhadj, S., Berger, L., Blok, M. J., Boonen, S. E., Borde, J., … Walker, L. C. (2022). Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers. Communications Biology, 5(1). https://doi.org/10.1038/s42003-022-03978-6

Kinslow, C. J., Tang, A., Chaudhary, K. R., & Cheng, S. K. (2022). Prevalence of Estrogen Receptor Alpha (ESR1) Somatic Mutations in Breast Cancer. JNCI Cancer Spectrum, 6(5). https://doi.org/10.1093/jncics/pkac060

Brotzman, L. E., Shelton, R. C., Austin, J. D., Rodriguez, C. B., Agovino, M., Moise, N., & Tehranifar, P. (2022). “It’s something I’ll do until I die”: A qualitative examination into why older women in the U.S. continue screening mammography. Cancer Medicine, 11(20), 3854–3862. Portico. https://doi.org/10.1002/cam4.4758

Murphy, A. I., Asadourian, P. A., Mellia, J. A., & Rohde, C. H. (2022). Complications Associated with Contralateral Prophylactic Mastectomy: A Systematic Review and Meta-Analysis. Plastic & Reconstructive Surgery. https://doi.org/10.1097/prs.0000000000009493

Houghton, L. C., Wei, Y., Wang, T., Goldberg, M., Paniagua-Avila, A., Sweeden, R. L., Bradbury, A., Daly, M., Schwartz, L. A., Keegan, T., John, E. M., Knight, J. A., Andrulis, I. L., Buys, S. S., Frost, C. J., O’Toole, K., White, M. L., Chung, W. K., & Terry, M. B. (2022). Body mass index rebound and pubertal timing in girls with and without a family history of breast cancer: the LEGACY girls study. International Journal of Epidemiology, 51(5), 1546–1555. https://doi.org/10.1093/ije/dyac021

Dixon-Suen, S. C., Lewis, S. J., Martin, R. M., English, D. R., Boyle, T., Giles, G. G., Michailidou, K., Bolla, M. K., Wang, Q., Dennis, J., Lush, M., Investigators, A., Ahearn, T. U., Ambrosone, C. B., Andrulis, I. L., Anton-Culver, H., Arndt, V., Aronson, K. J., Augustinsson, A., … Lynch, B. M. (2022). Physical activity, sedentary time and breast cancer risk: a Mendelian randomisation study. British Journal of Sports Medicine, 56(20), 1157–1170. https://doi.org/10.1136/bjsports-2021-105132

Crew, K. D., Bhatkhande, G., Silverman, T., Amenta, J., Jones, T., McGuinness, J. E., Mata, J., Guzman, A., He, T., Dimond, J., Tsai, W.-Y., & Kukafka, R. (2022). Patient and Provider Web-Based Decision Support for Breast Cancer Chemoprevention: A Randomized Controlled Trial. Cancer Prevention Research, 15(10), 689–700. https://doi.org/10.1158/1940-6207.capr-22-0013

Koelmeyer, L. A., Gaitatzis, K., Dietrich, M. S., Shah, C. S., Boyages, J., McLaughlin, S. A., Taback, B., Stolldorf, D. P., Elder, E., Hughes, T. M., French, J. R., Ngui, N., Hsu, J. M., Moore, A., & Ridner, S. H. (2022). Risk factors for breast cancer–related lymphedema in patients undergoing 3 years of prospective surveillance with intervention. Cancer, 128(18), 3408–3415. Portico. https://doi.org/10.1002/cncr.34377

Santiago-Torres, M., Contento, I., Koch, P., Tsai, W.-Y., Gaffney, A. O., Marín-Chollom, A. M., Shi, Z., Ulanday, K. T., Shen, H., Hershman, D., & Greenlee, H. (2022). Associations Between Acculturation and Weight, Diet Quality, and Physical Activity Among Latina Breast Cancer Survivors: The ¡Mi Vida Saludable! Study. Journal of the Academy of Nutrition and Dietetics, 122(9), 1703–1716. https://doi.org/10.1016/j.jand.2022.04.002

O’Shaughnessy, J., Brufsky, A., Rugo, H. S., Tolaney, S. M., Punie, K., Sardesai, S., Hamilton, E., Loirat, D., Traina, T., Leon-Ferre, R., Hurvitz, S. A., Kalinsky, K., Bardia, A., Henry, S., Mayer, I., Zhu, Y., Phan, S., & Cortés, J. (2022). Analysis of patients without and with an initial triple-negative breast cancer diagnosis in the phase 3 randomized ASCENT study of sacituzumab govitecan in metastatic triple-negative breast cancer. Breast Cancer Research and Treatment, 195(2), 127–139. https://doi.org/10.1007/s10549-022-06602-7

Kinslow, C. J., Kim, A., Sanchez, G. I., Cheng, S. K., Kachnic, L. A., Neugut, A. I., & Horowitz, D. P. (2022). Incidence of Anaplastic Large-Cell Lymphoma of the Breast in the US, 2000 to 2018. JAMA Oncology, 8(9), 1354. https://doi.org/10.1001/jamaoncol.2022.2624

Ludwig, K. K., & Rao, R. (2022). ASO Author Reflections: Homing in on Safety—Home Recovery After Mastectomy. Annals of Surgical Oncology, 29(9), 5809–5810. https://doi.org/10.1245/s10434-022-11848-y

Rauh‐Hain, J. A., Zubizarreta, J., Nitecki, R., Melamed, A., Fu, S., Jorgensen, K., Brady, P. C., Baker, V. L., Chavez‐MacGregor, M., Giordano, S. H., & Keating, N. L. (2022). Survival outcomes following pregnancy or assisted reproductive technologies after breast cancer: A population‐based study. Cancer, 128(17), 3243–3253. Portico. https://doi.org/10.1002/cncr.34371

Matsuo, K., Mandelbaum, R., Deshpande, R. R., Nusbaum, D. J., Yoshihara, K., Machida, H., Bainvoll, L., Matsuzaki, S., Klar, M., Roman, L. D., & Wright, J. D. (2022). Population incidence and characteristics of secondary breast cancer after uterine cancer: a competing risk analysis. Archives of Gynecology and Obstetrics, 306(3), 865–874. https://doi.org/10.1007/s00404-022-06440-4

Iwai, Y., Prigoff, J. G., Sun, L., Wiechmann, L., Taback, B., Rao, R., & Ugras, S. K. (2022). Shaves off the Cavity or Specimen in Lumpectomy for Breast Cancer. Journal of Surgical Research, 277, 296–302. https://doi.org/10.1016/j.jss.2022.04.027

Pace, L. E., Dusengimana, J.-M. V., Hategekimana, V., Rugema, V., Umwizerwa, A., Frost, E., Kwait, D., Schleimer, L. E., Huang, C., Shyirambere, C., Bigirimana, J. B., Shulman, L. N., Mpunga, T., & Raza, S. (2022). Clinical Diagnoses and Outcomes After Diagnostic Breast Ultrasound by Nurses and General Practitioner Physicians in Rural Rwanda. Journal of the American College of Radiology, 19(8), 983–989. https://doi.org/10.1016/j.jacr.2022.04.009

Vanguri, R. S., Fenn, K. M., Kearney, M. R., Wang, Q., Guo, H., Marks, D. K., Chin, C., Alcus, C. F., Thompson, J. B., Leu, C.-S., Hibshoosh, H., Kalinsky, K. M., Mathews, J. C., Nadeem, S., Hollmann, T. J., & Connolly, E. P. (2022). Tumor Immune Microenvironment and Response to Neoadjuvant Chemotherapy in Hormone Receptor/HER2+ Early Stage Breast Cancer. Clinical Breast Cancer, 22(6), 538–546. https://doi.org/10.1016/j.clbc.2022.04.002

Geczik, A. M., Ferris, J. S., Terry, M. B., Andrulis, I. L., Buys, S. S., Daly, M. B., Hopper, J. L., John, E. M., Kurian, A. W., Southey, M. C., Liao, Y., & Genkinger, J. M. (2022). Adherence to the 2020 American Cancer Society Guideline for Cancer Prevention and risk of breast cancer for women at increased familial and genetic risk in the Breast Cancer Family Registry: an evaluation of the weight, physical activity, and alcohol consumption recommendations. Breast Cancer Research and Treatment, 194(3), 673–682. https://doi.org/10.1007/s10549-022-06656-7

Llanos, A. A. M., Aremu, J. B., Cheng, T.-Y. D., Chen, W., Chekmareva, M. A., Cespedes Feliciano, E. M., Qin, B., Lin, Y., Omene, C., Khoury, T., Hong, C.-C., Yao, S., Ambrosone, C. B., Bandera, E. V., & Demissie, K. (2022). Greater Body Fatness Is Associated With Higher Protein Expression of LEPR in Breast Tumor Tissues: A Cross-Sectional Analysis in the Women’s Circle of Health Study. Frontiers in Endocrinology, 13. https://doi.org/10.3389/fendo.2022.879164

Kukafka, R., Pan, S., Silverman, T., Zhang, T., Chung, W. K., Terry, M. B., Fleck, E., Younge, R. G., Trivedi, M. S., McGuinness, J. E., He, T., Dimond, J., & Crew, K. D. (2022). Patient and Clinician Decision Support to Increase Genetic Counseling for Hereditary Breast and Ovarian Cancer Syndrome in Primary Care. JAMA Network Open, 5(7), e2222092. https://doi.org/10.1001/jamanetworkopen.2022.22092

Ayeni, O. A., O’Neil, D. S., Pumpalova, Y. S., Chen, W. C., Nietz, S., Phakathi, B., Buccimazza, I., Čačala, S., Stopforth, L. W., Farrow, H. A., Mapanga, W., Joffe, M., Chirwa, T., McCormack, V., Jacobson, J. S., Crew, K. D., Neugut, A. I., Ruff, P., & Cubasch, H. (2022). Impact of HIV infection on survival among women with stage I‐III breast cancer: Results from the South African breast cancer and HIV outcomes study. International Journal of Cancer, 151(2), 209–221. Portico. https://doi.org/10.1002/ijc.33981

Qin, B., Kim, K., Goldman, N., Rundle, A. G., Chanumolu, D., Zeinomar, N., Xu, B., Pawlish, K. S., Ambrosone, C. B., Demissie, K., Hong, C.-C., Lovasi, G. S., & Bandera, E. V. (2022). Multilevel Factors for Adiposity Change in a Population-Based Prospective Study of Black Breast Cancer Survivors. Journal of Clinical Oncology, 40(20), 2213–2223. https://doi.org/10.1200/jco.21.02973

Singhal, S. K., Byun, J. S., Yan, T., Yancey, R., Caban, A., Gil Hernandez, S., Bufford, S., Hewitt, S. M., Winfield, J., Pradhan, J., Mustkov, V., McDonald, J. A., Pérez-Stable, E. J., Nápoles, A. M., Vohra, N., De Siervi, A., Yates, C., Davis, M. B., Yang, M., … Gardner, K. (2022). Protein expression of the gp78 E3 ligase predicts poor breast cancer outcome based on race. JCI Insight, 7(13). https://doi.org/10.1172/jci.insight.157465

Plascak, J. J., Beyer, K., Xu, X., Stroup, A. M., Jacob, G., & Llanos, A. A. M. (2022). Association Between Residence in Historically Redlined Districts Indicative of Structural Racism and Racial and Ethnic Disparities in Breast Cancer Outcomes. JAMA Network Open, 5(7), e2220908. https://doi.org/10.1001/jamanetworkopen.2022.20908

McGuinness, J. E., Ro, V., Mutasa, S., Pan, S., Hu, J., Trivedi, M. S., Accordino, M. K., Kalinsky, K., Hershman, D. L., Ha, R. S., & Crew, K. D. (2022). Use of a convolutional neural network-based mammographic evaluation to predict breast cancer recurrence among women with hormone receptor-positive operable breast cancer. Breast Cancer Research and Treatment, 194(1), 35–47. https://doi.org/10.1007/s10549-022-06614-3

McGuinness, J. E., Bhatkhande, G., Amenta, J., Silverman, T., Mata, J., Guzman, A., He, T., Dimond, J., Jones, T., Kukafka, R., & Crew, K. D. (2022). Strategies to Identify and Recruit Women at High Risk for Breast Cancer to a Randomized Controlled Trial of Web-based Decision Support Tools. Cancer Prevention Research, 15(6), 399–406. https://doi.org/10.1158/1940-6207.capr-21-0593

Wooster, M., McGuinness, J. E., Fenn, K. M., Singh, V. M., Franks, L. E., Lee, S., Cieremans, D., Lassman, A. B., Hershman, D. L., Crew, K. D., Accordino, M. K., Trivedi, M. S., Iwamoto, F., Welch, M. R., Haggiagi, A., Schultz, R. D., Huynh, L., Sales, E., Fisher, D., … Kalinsky, K. (2022). Diagnosis of Leptomeningeal Metastasis in Women With Breast Cancer Through Identification of Tumor Cells in Cerebrospinal Fluid Using the CNSide™ Assay. Clinical Breast Cancer, 22(4), e457–e462. https://doi.org/10.1016/j.clbc.2021.11.002

Kwan, M. L., Cheng, R. K., Iribarren, C., Shen, H., Laurent, C. A., Roh, J. M., Hershman, D. L., Kushi, L. H., Greenlee, H., & Rana, J. S. (2022). Risk of heart failure with preserved versus reduced ejection fraction in women with breast cancer. Breast Cancer Research and Treatment, 193(3), 669–675. https://doi.org/10.1007/s10549-022-06586-4

Jairam, M. P., & Ha, R. (2022). A review of artificial intelligence in mammography. Clinical Imaging, 88, 36–44. https://doi.org/10.1016/j.clinimag.2022.05.005

Goodwin, P. J., Chen, B. E., Gelmon, K. A., Whelan, T. J., Ennis, M., Lemieux, J., Ligibel, J. A., Hershman, D. L., Mayer, I. A., Hobday, T. J., Bliss, J. M., Rastogi, P., Rabaglio-Poretti, M., Mukherjee, S. D., Mackey, J. R., Abramson, V. G., Oja, C., Wesolowski, R., Thompson, A. M., … Parulekar, W. R. (2022). Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer. JAMA, 327(20), 1963. https://doi.org/10.1001/jama.2022.6147

Greenlee, H., Iribarren, C., Rana, J. S., Cheng, R., Nguyen-Huynh, M., Rillamas-Sun, E., Shi, Z., Laurent, C. A., Lee, V. S., Roh, J. M., Santiago-Torres, M., Shen, H., Hershman, D. L., Kushi, L. H., Neugebauer, R., & Kwan, M. L. (2022). Risk of Cardiovascular Disease in Women With and Without Breast Cancer: The Pathways Heart Study. Journal of Clinical Oncology, 40(15), 1647–1658. https://doi.org/10.1200/jco.21.01736

Korde, L. A., Somerfield, M. R., & Hershman, D. L. (2022). Use of Immune Checkpoint Inhibitor Pembrolizumab in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update. Journal of Clinical Oncology, 40(15), 1696–1698. https://doi.org/10.1200/jco.22.00503

Kwan, M. L., Cheng, R. K., Iribarren, C., Neugebauer, R., Rana, J. S., Nguyen-Huynh, M., Shi, Z., Laurent, C. A., Lee, V. S., Roh, J. M., Shen, H., Rillamas-Sun, E., Santiago-Torres, M., Hershman, D. L., Kushi, L. H., & Greenlee, H. (2022). Risk of Cardiometabolic Risk Factors in Women With and Without a History of Breast Cancer: The Pathways Heart Study. Journal of Clinical Oncology, 40(15), 1635–1646. https://doi.org/10.1200/jco.21.01738

Li, S., Silvestri, V., Leslie, G., Rebbeck, T. R., Neuhausen, S. L., Hopper, J. L., Nielsen, H. R., Lee, A., Yang, X., McGuffog, L., Parsons, M. T., Andrulis, I. L., Arnold, N., Belotti, M., Borg, Å., Buecher, B., Buys, S. S., Caputo, S. M., Chung, W. K., … Antoniou, A. C. (2022). Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants. Journal of Clinical Oncology, 40(14), 1529–1541. https://doi.org/10.1200/jco.21.02112

Lifrieri, A., Fuzesi, S., Desperito, E., & Taback, B. (2022). When the clipped node goes missing, CT guided SAVI SCOUT placement: A novel approach for localizing soft tissue targets. Clinical Imaging, 85, 115–117. https://doi.org/10.1016/j.clinimag.2022.03.003

Vasan, N., & Cantley, L. C. (2022). At a crossroads: how to translate the roles of PI3K in oncogenic and metabolic signalling into improvements in cancer therapy. Nature Reviews Clinical Oncology, 19(7), 471–485. https://doi.org/10.1038/s41571-022-00633-1

Lin, P.-H., Chen, S.-C., Tseng, L.-M., Chang, K.-J., Huang, A.-C., Cheng, K.-C., Yang, K., Wu, H.-C., Chao, T.-Y., Chang, Y.-C., Lin, P.-C., Kuo, W.-H., Kuo, W.-L., Lin, C.-H., Chen, H.-M., Yeh, D.-C., Liu, L.-C., Liu, C.-Y., Wang, M.-Y., … Huang, C.-S. (2022). Impact of BRCA mutation on the survival and risk of contralateral breast cancer in Asian breast cancer patients. Breast Cancer Research and Treatment, 192(3), 629–637. https://doi.org/10.1007/s10549-021-06446-7

Westhoff, C. L., Guo, H., Wang, Z., Hibshoosh, H., Polaneczky, M., Pike, M. C., & Ha, R. (2022). The progesterone-receptor modulator, ulipristal acetate, drastically lowers breast cell proliferation. Breast Cancer Research and Treatment, 192(2), 321–329. https://doi.org/10.1007/s10549-021-06503-1

Pumpalova, Y. S., Ayeni, O. A., Chen, W. C., Buccimazza, I., Cačala, S., Stopforth, L. W., Farrow, H. A., Mapanga, W., Nietz, S., Phakathi, B., Joffe, M., McCormack, V., Jacobson, J. S., Crew, K. D., Neugut, A. I., Ruff, P., Cubasch, H., & O’Neil, D. S. (2022). The Impact of Breast Cancer Treatment Delays on Survival Among South African Women. The Oncologist, 27(3), e233–e243. https://doi.org/10.1093/oncolo/oyab054

Simonds, H. M., & Jacobson, J. S. (2022). Breast cancer survival in women living with HIV. The Lancet HIV, 9(3), e141–e142. https://doi.org/10.1016/s2352-3018(22)00010-8

Ye, Z., Li, S., Dite, G. S., Nguyen, T. L., MacInnis, R. J., Andrulis, I. L., Buys, S. S., Daly, M. B., John, E. M., Kurian, A. W., Genkinger, J. M., Chung, W. K., Phillips, K.-A., Thorne, H., Thorne, H., Winship, I. M., Milne, R. L., Dugué, P.-A., … Hopper, J. L. (2022). Weight is More Informative than Body Mass Index for Predicting Postmenopausal Breast Cancer Risk: Prospective Family Study Cohort (ProF-SC). Cancer Prevention Research, 15(3), 185–191. https://doi.org/10.1158/1940-6207.capr-21-0164

Marano, A. A., Grover, K., Peysakhovich, A., Lin, A. J., Castillo, W., & Rohde, C. H. (2022). Comparing Outcomes after Oncoplastic Breast Reduction and Breast Reduction for Benign Macromastia. Plastic & Reconstructive Surgery, 149(3), 541–548. https://doi.org/10.1097/prs.0000000000008822

Acheampong, T., Lee Argov, E. J., Terry, M. B., Rodriguez, C. B., Agovino, M., Wei, Y., Athilat, S., & Tehranifar, P. (2022). Current regular aspirin use and mammographic breast density: a cross-sectional analysis considering concurrent statin and metformin use. Cancer Causes & Control, 33(3), 363–371. https://doi.org/10.1007/s10552-021-01530-1

Dareng, E. O., Tyrer, J. P., Barnes, D. R., Jones, M. R., Yang, X., Aben, K. K. H., Adank, M. A., Agata, S., Andrulis, I. L., Anton-Culver, H., Antonenkova, N. N., Aravantinos, G., Arun, B. K., Augustinsson, A., Balmaña, J., Bandera, E. V., Barkardottir, R. B., Barrowdale, D., Beckmann, M. W., … Pharoah, P. D. P. (2022). Polygenic risk modeling for prediction of epithelial ovarian cancer risk. European Journal of Human Genetics, 30(3), 349–362. https://doi.org/10.1038/s41431-021-00987-7